Table 2

Treatment effects ofNigella sativaand placebo on fasting blood glucose (FBG) and blood pressure levels
Parameters Baseline 1stmonth 2ndmonth Follow up
N. sativa Placebo N. sativa Placebo N. sativa Placebo N. sativa Placebo
FBG (mmol/L) 6.37 ± 0.61* 5.94 ± 0.44 5.69 ± 0.43* 5.81 ± 0.31 5.03 ± 0.51* 5.73 ± 0.75 5.48 ± 0.42* 5.70 ± 0.66
SBP (mmHg) 129.33 ± 15.44 138.40 ± 18.90 121.80 ± 17.40 131.27 ± 19.22 124.53 ± 13.31 140.71 ± 11.85 125.84 ± 15.48 144.71 ± 19.84
DBP (mmHg) 77.13 ± 9.16 83.93 ± 15.73 76.00 ± 12.90 79.53 ± 13.83 75.53 ± 9.56 89.00 ± 12.53 75.98 ± 10.64 93.00 ± 15.16

Values are mean ± SD. There was a downward trend in the means of the groups for both N. sativa and placebo over 2 months of intervention but no significant differences were observed.

*Significant between N. S vs. placebo group at p < 0.05. SBP: systolic blood pressure; DBP: diastolic blood pressure.

Ibrahim et al.

Ibrahim et al. Journal of Translational Medicine 2014 12:82   doi:10.1186/1479-5876-12-82

Open Data